Mental Health Policy and Psychotropic Drugs
The pace of innovation in psychotropic drugs has been rapid over the past 15 years. There also have been unprecedented increases in spending on prescription drugs generally and psychotropic medications specifically. Psychotropic medications are playing a more central role in treatment. They also... Full description
| 1st Person: | Frank, Richard G. |
|---|---|
| Additional Persons: | Conti, Rena M. verfasserin; Goldman, Howard H. verfasserin |
| Source: |
in The Milbank quarterly : a journal of public health and health care policy Vol. 83, No. 2 (2005), p. 271-298  More Articles |
| Type of Publication: | Article |
| Language: | English |
| Published: |
2005 |
| Keywords: |
research-article
Psychotropic drugs Mental health treatment Mental health policy Managed behavioral healthcare |
| Online: |
Volltext |
|
| LEADER | 01975nma a2200337 c 4500 | ||
|---|---|---|---|
| 001 | JST058170049 | ||
| 003 | DE-601 | ||
| 005 | 20180602225117.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 150325s2005 000 0 eng d | ||
| 024 | 8 | |a 30045615 | |
| 035 | |a 30045615 | ||
| 040 | |b ger |c GBVCP | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Frank, Richard G. | |
| 245 | 1 | 0 | |a Mental Health Policy and Psychotropic Drugs |h Elektronische Ressource |
| 300 | |a Online-Ressource | ||
| 500 | |a Copyright: Copyright 2005 Milbank Memorial Fund | ||
| 520 | |a The pace of innovation in psychotropic drugs has been rapid over the past 15 years. There also have been unprecedented increases in spending on prescription drugs generally and psychotropic medications specifically. Psychotropic medications are playing a more central role in treatment. They also are receiving close scrutiny from health insurers, state budget makers, and ordinary citizens. Public policy actions regarding prescription drugs have the potential to significantly affect clinical care for mental disorders, the costs of this care to individuals and society at large, and the prospects for future scientific advances. This article outlines the policy issues related to psychotropic drugs with respect to their role in determining access to mental health treatment and the cost and quality of mental health care. | ||
| 653 | |a research-article | ||
| 653 | |a Psychotropic drugs | ||
| 653 | |a Mental health treatment | ||
| 653 | |a Mental health policy | ||
| 653 | |a Managed behavioral healthcare | ||
| 700 | 1 | |a Conti, Rena M. |e verfasserin |4 aut | |
| 700 | 1 | |a Goldman, Howard H. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i in |t The Milbank quarterly : a journal of public health and health care policy |d Oxford : Wiley-Blackwell |g Vol. 83, No. 2 (2005), p. 271-298 |q 83:2<271-298 |w (DE-601)JST058162925 |x 0887-378X |
| 856 | 4 | 1 | |u https://www.jstor.org/stable/30045615 |3 Volltext |
| 912 | |a GBV_JSTOR | ||
| 951 | |a AR | ||
| 952 | |d 83 |j 2005 |e 2 |h 271-298 | ||